Author: claimsbot

1. A method of testing a power level and oscillator frequency of a power amplifier in an integrated circuit based transmitter, said method comprising the steps of:
comparing a power amplifier output to a threshold and generating a square wave signal in response thereto, said threshold being adjusted such that said square wave signal is generated only when said power amplifier output voltage amplitude is above a predetermined level;
dividing said square wave signal a sufficient number of times to enable frequency counting of a test output generated therefrom at a frequency significantly below that of said oscillator frequency;

wherein a frequency count of zero or significantly below an expected level indicates a failure of said power amplifier to generate an acceptable output power level; and
wherein said predetermined level is set to screen said transmitter for compliance with a minimum power output level by said power amplifier.
2. The method according to claim 1, wherein said threshold is dynamically configurable.
3. The method according to claim 1, wherein said step of dividing comprises the step of dividing said square wave to a sufficiently low frequency to permit frequency counting using relatively low cost external test equipment.
4. The method according to claim 1, wherein said step of dividing comprises the step of dividing said square wave to a sufficiently low frequency thereby permitting frequency counting using existing on-chip processing means adapted to perform frequency counting.
5. The method according to claim 1, wherein said step of dividing comprises, for a 2.4 GHz oscillator frequency, the step of dividing said square wave by 128 to yield approximately a 19 MHz test output signal.
6. The method according to claim 1, wherein the division ratio for said square wave is divided is dynamically configurable.
7. The method according to claim 1, further comprising the step of applying said test output signal to a relatively low cost external frequency counter to verify compliance with a desired oscillator frequency.
8. The method according to claim 1, further comprising the step of applying said test output signal to an on-chip softwarehardware based block adapted to verify compliance with a desired oscillator frequency range by means of frequency counting.
9. The method according to claim 1, wherein said oscillator frequency signal comprises carrier signal only.
10. The method according to claim 1, wherein said oscillator frequency signal comprises carrier signal combined with a modulating signal.
11. An apparatus for testing a power level and oscillator frequency of a power amplifier in an integrated circuit based transmitter, comprising:
means for comparing a power amplifier output to a threshold and generating a square wave signal in response thereto, said threshold being adjusted such that said square wave signal is generated only when said power amplifier output voltage amplitude is above a predetermined level;
means for dividing said square wave signal a sufficient number of times so as to enable frequency counting of a test output generated therefrom at a frequency significantly below that of said oscillator frequency;

wherein a frequency count of zero or significantly below an expected value indicates a failure of said power amplifier to generate an acceptable output power level; and
wherein said predetermined level is set to screen said transmitter for compliance with a minimum power output level by said power amplifier.
12. The apparatus according to claim 11, wherein said threshold is dynamically configurable.
13. The apparatus according to claim 11, wherein said means for dividing is adapted to divide said square wave to a sufficiently low frequency to permit frequency counting using relatively low Cost external test equipment.
14. The apparatus according to claim 11, wherein said means for dividing is adapted to divide said square wave, derived from a 2.4 GHz oscillator frequency, by 128 to yield approximately a 19 MHz test Output signal.
15. The apparatus according to claim 11, wherein the division ratio by which the frequency of said square wave is divided is dynamically configurable.
16. The apparatus according to claim 11, further comprising means for applying said test output signal to a relatively low cost external frequency Counter to verify compliance with a desired oscillator frequency.
17. The apparatus according to claim 11, wherein said oscillator frequency signal comprises carrier signal only.
18. The apparatus according to claim 11, wherein said oscillator frequency signal comprises carrier signal combined with a modulating signal.
19. An apparatus for testing a power level and oscillator frequency of a power amplifier in an integrated circuit based transmitter, comprising:
a comparator having a first input and a second input, wherein a power amplifier output signal is connected to said first input and a threshold signal is connected to said second input, said comparator operative to produce a square wave signal, wherein said threshold being adjusted such that said square wave signal is generated only when said power amplifier output voltage amplitude is above a predetermined level;
a frequency divider adapted to receive the square wave signal output of said comparator and adapted to divide the frequency of said square wave to within a frequency range sufficiently below that of said oscillator frequency;
wherein a frequency count of zero indicates a failure of said power amplifier to generate an acceptable output power level; and
wherein said predetermined level is set to screen said transmitter for compliance with a minimum power output level by said power amplifier.
20. The apparatus according to claim 19, further comprising a configurable threshold register coupled to said second input of said comparator through a digital-to-analog converter, wherein said threshold register is adapted to be configurable via software or hardware means.
21. The apparatus according to claim 19, wherein said frequency divider is configurable and coupled to a configurable division register, wherein said division register is adapted to be configurable via software or hardware means.
22. The apparatus according to claim 19, wherein said threshold is dynamically configurable.
23. The apparatus according to claim 19, wherein said means for dividing is adapted to divide said square wave to a sufficiently low frequency to permit frequency counting using relatively low cost external test equipment.
24. The apparatus according to claim 19, wherein said means for dividing is adapted to divide said square wave to a sufficiently low frequency to permit frequency counting using internal processing means.
25. The apparatus according to claim 19, wherein said frequency divider is adapted to divide the frequency of said square wave to within a frequency range sufficiently below that of said oscillator frequency to enable frequency counting by on-chip processor means utilizing appropriate software adapted to execute on said processor means.
26. The apparatus according to claim 19, wherein said means for dividing is adapted to divide said square wave, derived from a 2.4 GHz oscillator frequency, by 128 to yield approximately a 19 MHz test output signal.
27. The apparatus according to claim 19, wherein the division ratio for said square wave is divided is dynamically configurable.
28. The apparatus according to claim 19, further comprising means for applying said test output signal to a relatively low cost external frequency counter to verify compliance with a desired oscillator frequency.
29. The apparatus according to claim 19, wherein said oscillator frequency signal comprises carrier signal only.
30. The apparatus according to claim 19, wherein said oscillator frequency signal comprises carrier signal combined with a modulating signal.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method of treating digestive ailments in animals comprising administering to an animal in need of same an effective amount of a composition comprising at least one natural alumino-silicate mineral which has been irradiated with transverse electromagnetic wave radiation in the range of 1,800 MHz to 3,000 MHz.
2. A process for producing a composition comprising natural alumino-silicate minerals having improved reactivity for use in methods of animal husbandry, veterinary and pharmaceutical treatment, comprising irradiating natural alumino-silicate minerals in a liquid suspension with transverse electromagnetic wave radiation in the range of 1,800 MHz to 3,000 MHz, the liquid suspension having a boiling temperature of below 120\xb0 C.
3. A composition comprising natural alumino-silicate minerals having improved reactivity for use in methods of animal husbandry, veterinary and pharmaceutical treatment when produced by the process of claim 2.
4. A method of healing wounds in mammals comprising administering to a mammal in need of same an effective amount of a composition comprising at least one natural alumino-silicate mineral which has been irradiated with transverse electromagnetic wave radiation in the range of 1,800 MHz to 3,000 MHz.
5. The composition of claim 3 wherein the natural alumino-silicate minerals include natural zeolite minerals.
6. The composition of claim 5 wherein the natural zeolite minerals are selected from the group consisting of clinoptilolite, mordenite, chabazite, erionite and stellerite.
7. The composition of claim 3 wherein the liquid suspension is a water based suspension.
8. The composition of claim 3 wherein the natural alumino-silicate minerals include bentonite to maintain the natural zeolite minerals in suspension.
9. The composition of claim 3 wherein the natural alumino-silicate minerals comprise 70% ww zeolite, 28% ww kaolinite, and 2% ww bentonite.

1. A substrate, comprising:
a handle support; and
a single crystalline layer on the handle support, wherein the single crystalline layer is substantially strain-relieved.
2. The substrate of claim 1, wherein the single crystalline layer is completely strain-relieved.
3. The substrate of claim 1, wherein the single crystalline layer comprises a material selected from the group consisting of III-V semiconductor materials, II-VI semiconductor materials, IV-IV semiconductor materials, and ceramic semiconductor materials.
4. The substrate of claim 3, wherein the single crystalline layer comprises a III-V semiconductor material.
5. The substrate of claim 4, wherein the single crystalline layer comprises an alloy of In, Ga and As.
6. The substrate of claim 1, wherein the handle support comprises Si.
7. The substrate of claim 1, wherein the handle support comprises a SiO2Si substrate.
8. A method of forming a virtual substrate, comprising:
growing a coherently-strained single crystalline layer on an initial growth substrate;
removing the initial growth substrate from the coherently-strained single crystalline layer, wherein upon removal of the initial growth substrate, the coherently-strained single crystalline layer is substantially relieved of strain to form a substantially strain-relieved single crystalline layer; and
applying the substantially strain-relieved single crystalline layer to a handle support to form the virtual substrate.
9. The method of claim 8, wherein the substantially strain-relieved single crystalline layer is completely relieved of strain.
10. The method of claim 8, further comprising applying a transfer support to the coherently-strained single crystalline layer prior to removing the initial growth substrate.
11. The method of claim 10, wherein the transfer support comprises a material selected from the group consisting of waxes, greases, polymers, adhesives and adhesive tapes.
12. The method of claim 10, further comprising removing the transfer support after applying the substantially strain-relieved single crystalline layer to the handle support.
13. The method of claim 8, wherein the applying the substantially strain-relieved single crystalline layer to the handle support comprises applying water to at least one of the substantially strain-relieved single crystalline layer or the handle support, and allowing a van der Waals bond to form between the substantially strain-relieved single crystalline layer and the handle support.
14. The method of claim 8, further comprising applying a sacrificial layer on the initial growth substrate prior to growing the coherently-strained single crystalline layer, wherein the coherently-strained single crystalline layer is grown on the sacrificial layer.
15. The method of claim 14, wherein the removing the initial growth substrate from the coherently-strained single crystalline layer comprises removing the sacrificial layer.
16. The method of claim 15, further comprising applying a transfer support to the coherently-strained single crystalline layer prior to removing the sacrificial layer.
17. The method of claim 16, further comprising removing the transfer support after applying the substantially strain-relieved single crystalline layer to the handle support.
18. The method of claim 8, further comprising implanting H+ or He+ ions in the initial growth substrate after growing the coherently-strained film.
19. The method of claim 18, wherein removing the initial growth substrate from the coherently-strained single crystalline layer comprises:
heating the initial growth substrate and coherently-strained single crystalline layer after implanting the ions, wherein the heat triggers exfoliation of the initial growth substrate resulting in removal of all but a thin layer of the initial growth substrate from the coherently-strained single crystalline layer; and
removing the thin layer of the initial growth substrate from the coherently-strained single crystalline layer.
20. The method of claim 19, further comprising applying a transfer support to the coherently-strained single crystalline layer prior to heating the initial growth substrate and coherently-strained single crystalline layer.
21. The method of claim 20, further comprising removing the transfer support after applying the substantially strain-relieved single crystalline layer to the handle support.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1-13. (canceled)
14. A veterinary or agricultural composition comprising a compound of Formula (1),
wherein:
X is CR8;
R1 is CF3, OCF2H, OCF3, \u2014SCF3, \u2014SOCF3, \u2014SO2CF3, or SF5;
R2 is H, fluoro, or C1-4 alkyl optionally substituted by 1 to 5 halogen atoms independently selected from chloro and fluoro;
R3, R4, R5, and R6 are independently selected from hydrogen, chloro, fluoro, and C4 alkyl optionally substituted by 1 to 5 halogen groups independently selected from chloro and fluoro;
R7 is Cl or fluoro;
R8 is Cl or fluoro; and
R9 is NRaRb;
Ra is selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-8 cycloalkyl, C(O)OC1-6 alkyl and C1-6 alkanoyl, wherein each of the above groups may include one or more optional substituents where chemically possible independently selected from halo, phenyl, hydroxy, \u2014C(O)OH, \u2014C(O)OC1-6 alkyl, C1-6 alkyl, C1-6 haloalkyl, C3-8 cycloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, amino, C1-6 alkyl amino and di C1-6 alkyl amino;
Rb is selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C1-6 alkanoyl and C(O)OC1-6 alkyl, wherein each of the above groups may include one or more optional substituents where chemically possible independently selected from halo, phenyl, hydroxy, \u2014COOH, \u2014C(O)OC1-6 alkyl, C1-6 alkyl, C1-6 haloalkyl, C3-8 cycloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, amino, C1-6 alkyl amino and di C1-6 alkyl amino; or a veterinarily, or agriculturally acceptable salt thereof; with the proviso that at least one of R2, R3, R4, R5, or R6 is fluoro, and optionally, a veterinarily or agriculturally acceptable excipient.
15. The composition of claim 14, wherein R1 is CF3 or SF5.
16. The composition of claim 15, wherein R2 is F, CF3 or CHF2.
17. The composition of claim 16, wherein R3 and R4 are each fluoro and R5 and R6 are each hydrogen.
18. The composition of claim 17, wherein R2 is CF3, R3 and R4 both represent fluoro and R5 and R6 represent hydrogen.
19. The composition of claim 18, wherein R7 and R8 are both chloro.
20. The composition of claim 19, wherein R9 is NH2.
21. The composition of claim 14, further comprising a veterinarily or agriculturally acceptable excipient.
22. The composition of claim 14, wherein the Formula (1) compound is selected from:
5-amino-1-2,6-dichloro-4-pentafluorothiophenyl-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-(1,2,2-trifluorocyclopropyl)-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-(pentafluorocyclopropyl)-1H-pyrazole-3-carbonitrile;
5-amino-4-(2,2-dichloro-1-fluorocyclopropyl)-1-2,6-dichloro-4-(trifluoromethyl)phenyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-pentafluorothiophenyl-4-(pentafluorocyclopropyl)-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-pentafluorothiophenyl-4-(1,2,2-trifluorocyclopropyl)-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-1-(difluoromethyl)-2,2-difluorocyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-(2,2-difluorocyclopropyl)-1H-pyrazole-3-carbonitrile;
5-amino-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1-2,6-difluoro-4-(trifluoromethyl)phenyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-pentafluorothiophenyl-4-1-(difluoromethyl)-2,2-difluorocyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-4-{1-chloro(fluoro)methyl-2,2-difluorocyclopropyl}1-2,6-dichloro-4-(trifluoromethyl)phenyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-1-(difluoromethyl)-2,2,3,3-tetrafluorocyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-2,2,3,3-tetrafluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazole-3-carbonitrile:
1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-5-(methylamino)-1H-pyrazole-3-carbonitrile
5-amino-1-2,6-dichloro-4-(trifluoromethoxy)phenyl-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethoxy)phenyl-4-1-(difluoromethyl)-2,2,3,3-tetrafluorocyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethoxy)phenyl-4-1-(difluoromethyl)-2,2-difluorocyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-2,2-difluoro-1-(fluoromethyl)cyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-(2,2-difluoro-1-methylcyclopropyl)-1H-pyrazole-3-carbonitrile;
5-amino-1-{2,6-dichloro-4-(trifluoromethyl)thiophenyl}-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazole-3-carbonitrile;
ethyl 3-cyano-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazol-5-ylcarbamate;
2-(dimethylamino)ethyl 3-cyano-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazol-5-ylcarbamate;
2,2,2-trifluoroethyl 3-cyano-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazol-5-ylcarbamate;
5-amino-1-{2,6-dichloro-4-(trifluoromethyl)sulfonylphenyl}-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-(difluoromethoxy)phenyl-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazole-3-carbonitrile;
5-amino-1-2,6-dichloro-4-pentafluorothiophenyl-4-1-(difluoromethyl)-2,2,3,3-tetrafluorocyclopropyl-1H-pyrazole-3-carbonitrile;
Isopropyl 3-cyano-1-2,6-dichloro-4-(trifluoromethyl)phenyl-4-2,2-difluoro-1-(trifluoromethyl)cyclopropyl-1H-pyrazol-5-ylcarbamate; and
5-amino-4-{1-chloro(difluoro)methyl-2,2-difluorocyclopropyl}-1-2,6-dichloro-4-(trifluoromethyl)phenyl-1H-pyrazole-3-carbonitrile, or a veterinarily, or agriculturally acceptable salt thereof.
23. A method of using a compound of Formula (I),
wherein:
X is CR8;
R1 is CF3, OCF2H, OCF3, \u2014SCF3, \u2014SOCF3, \u2014SO2CF3, or SF5;
R2 is H, fluoro, or C1-4 alkyl optionally substituted by 1 to 5 halogen atoms independently selected from chloro and fluoro;
R3, R4, R5, and R6 are independently selected from hydrogen, chloro, fluoro, and C1-4 alkyl optionally substituted by 1 to 5 halogen groups independently selected from chloro and fluoro;
R7 is Cl or fluoro;
R8 is Cl or fluoro; and
R9 is NRaRb;
Ra is selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-8 cycloalkyl, C(O)OC1-6 alkyl and C1-6 alkanoyl, wherein each of the above groups may include one or more optional substituents where chemically possible independently selected from halo, phenyl, hydroxy, \u2014C(O)OH, \u2014C(O)OC1-8 alkyl, C1-6 alkyl, C1-6 haloalkyl, C3-8 cycloalkyl, C alkoxy, C1-6 haloalkoxy, amino, C1-6 alkyl amino and di C1-e, alkyl amino;
Rb is selected from hydrogen, C1-6 alkyl, C2-6 alkenyl, C1-6 alkanoyl and C(O)OC1-6 alkyl, wherein each of the above groups may include one or more optional substituents where chemically possible independently selected from, halo, phenyl, hydroxy, \u2014COOH, \u2014C(O)OC1-6 alkyl, C1-6 alkyl, C1-6 haloalkyl, C3-8 cycloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, amino, C1-6 alkyl amino and di C1-6 alkyl amino; or a veterinarily, or agriculturally acceptable salt thereof; with the proviso that at least one of R2, R3, R4, R5, or R6 is fluoro; for the control of a parasitic infestation in an animal or plant.
24. The method of claim 23, wherein the control of a parasitic infestation is in an animal.
25. The method of claim 23, wherein the control of a parasitic infestation is in a plant.